Understanding the Legal Landscape with Semaglutide

Medical Spa Insider

Inhoud geleverd door American Med Spa Association - AmSpa. Alle podcastinhoud, inclusief afleveringen, afbeeldingen en podcastbeschrijvingen, wordt rechtstreeks geüpload en geleverd door American Med Spa Association - AmSpa of hun podcastplatformpartner. Als u denkt dat iemand uw auteursrechtelijk beschermde werk zonder uw toestemming gebruikt, kunt u het hier beschreven proces https://nl.player.fm/legal volgen.

12M ago 31:42

MP3•Thuis aflevering

This week, AmSpa CEO, Alex R. Thiersch, JD, speaks with Patrick O’Brien, JD, of AmSpa and ByrdAdatto, to discuss the legal concerns with compounded semaglutide and its name-brand drugs. They talk about the basic legal implications of Ozempic and recent lawsuits, compounding pharmacy issues and general guidelines for navigating this area of the law. Their conversation includes:

How compounding pharmacies began compounding semaglutide;
Patent protections for the name-brand manufacturer;
Semaglutide salts and FDA warnings about base ingredients;
The recent lawsuits and the issues at play;
Trademarks, advertising and claims;
How your medical spa can stay compliant when offering compounded semaglutide;
And more!

Read more about the ongoing lawsuits filed by Novo Nordisk, maker of Ozempic and Wegovy, at the AmSpa Now blog. Stay tuned for new updates on the subject as more info becomes available.

This episode of Medical Spa Insider is sponsored by RepeatMD. Visit https://www.repeatmd.com/ to learn more!

103 afleveringen

#Business #MBA #Fitness #Entrepreneur #Medicine #American Med Spa Association - AmSpa